High mobility group AT-hook 2 is overexpressed in hepatoblastoma

Human Pathology

Volumn 44, Issue 5, 2013, Pages 802-810

  Lee, Chung Ta ^a   Zhang, Lizhi ^b   Mounajjed, Taofic ^b   Wu, Tsung Teh ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b MAYO CLINIC   (United States)

Author keywords

catenin; Glypican 3; Hepatoblastoma; Hepatocellular carcinoma; HMGA2; Immunohistochemistry

Indexed keywords

BETA CATENIN; GLYPICAN 3; HIGH MOBILITY GROUP A2 PROTEIN; KI 67 ANTIGEN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; GLYPICANS; HEPATOBLASTOMA; HMGA2 PROTEIN; HUMANS; INFANT; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84876487879     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.08.003     Document Type: Article

References (35)

1. J.E. Haas, K.A. Muczynski, and M. Krailo Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma Cancer 64 1989 1082 1095 (Pubitemid 19208862)
2. N. Hadzic, A. Quaglia, and B. Portmann Hepatocellular carcinoma in biliary atresia: King's College Hospital experience J Pediatr 159 2011 617 622
3. C.L. Lee, and Y.C. Ko Survival and distribution pattern of childhood liver cancer in Taiwan Eur J Cancer 34 1998 2064 2067
4. F. Ozcay, O. Canan, B. Bilezikci, A. Torgay, H. Karakayali, and M. Haberal Effect of living donor liver transplantation on outcome of children with inherited liver disease and hepatocellular carcinoma Clin Transplant 20 2006 776 782 (Pubitemid 44712280)
5. K. Dezso, J. Halasz, and H.C. Bisgaard Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas Virchows Arch 452 2008 443 448
6. S.C. Ward, S.N. Thung, and K.H. Lim Hepatic progenitor cells in liver cancers from Asian children Liver Int 30 2010 102 111
7. G.J. Gattas, B.J. Quade, R.A. Nowak, and C.C. Morton HMGIC expression in human adult and fetal tissues and in uterine leiomyomata Genes Chromosomes Cancer 25 1999 316 322 (Pubitemid 29326137)
8. A. Anand, and K. Chada In vivo modulation of Hmgic reduces obesity Nat Genet 24 2000 377 380 (Pubitemid 30187436)
9. S. Battista, V. Fidanza, and M. Fedele The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis Cancer Res 59 1999 4793 4797 (Pubitemid 29472878)
10. K. Monzen, Y. Ito, and A.T. Naito A crucial role of a high mobility group protein HMGA2 in cardiogenesis Nat Cell Biol 10 2008 567 574 (Pubitemid 351627376)
11. H. Sakai, Y. Tagawa, and M. Tamai Isolation and characterization of portal branch ligation-stimulated Hmga2-positive bipotent hepatic progenitor cells Biochem Biophys Res Commun 403 2010 298 304
12. B. Meyer, S. Loeschke, and A. Schultze HMGA2 overexpression in non-small cell lung cancer Mol Carcinog 46 2007 503 511 (Pubitemid 47068069)
13. K. Motoyama, H. Inoue, Y. Nakamura, H. Uetake, K. Sugihara, and M. Mori Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family Clin Cancer Res 14 2008 2334 2340 (Pubitemid 351551065)
14. A.C. Hristov, L. Cope, and M.D. Reyes HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma Mod Pathol 22 2009 43 49
15. A. Mahajan, Z. Liu, and L. Gellert HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma Mod Pathol 23 2010 673 681
16. X. Wang, X. Liu, and A.Y. Li Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers Clin Cancer Res 17 2011 2570 2580
17. R. Purcell, M. Childs, and R. Maibach Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study Eur J Cancer 48 2012 1853 1859
18. H.L. Wang, F. Anatelli, Q.J. Zhai, B. Adley, S.T. Chuang, and X.J. Yang Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions Arch Pathol Lab Med 132 2008 1723 1728
19. R. Franco, F. Esposito, and M. Fedele Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours J Pathol 214 2008 58 64
20. F. Cerignoli, C. Ambrosi, and M. Mellone HMGA molecules in neuroblastic tumors Ann N Y Acad Sci 1028 2004 122 132 (Pubitemid 40361816)
21. N. Venkatesan, M. Kandalam, and G. Pasricha Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features J Pediatr Hematol Oncol 31 2009 209 214
22. E. Davicioni, M.J. Anderson, and F.G. Finckenstein Molecular classification of rhabdomyosarcoma - genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group Am J Pathol 174 2009 550 564
23. K. Nejak-Bowen, and S.P. Monga Wnt/beta-catenin signaling in hepatic organogenesis Organogenesis 4 2008 92 99
24. M.C. Curia, M. Zuckermann, and L. De Lellis Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations Mod Pathol 21 2008 7 14
25. D. Lopez-Terrada, P.H. Gunaratne, and A.M. Adesina Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors Hum Pathol 40 2009 783 794
26. J.S. Lee, J. Heo, and L. Libbrecht A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
27. T. Yamashita, M. Forgues, and W. Wang EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461 (Pubitemid 351346853)
28. S. Inagawa, M. Itabashi, and S. Adachi Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival Clin Cancer Res 8 2002 450 456 (Pubitemid 34193964)
29. A. Zimmermann The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis Eur J Cancer 41 2005 1503 1514 (Pubitemid 40981831)
30. Y. Wei, M. Fabre, S. Branchereau, F. Gauthier, G. Perilongo, and M.A. Buendia Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas Oncogene 19 2000 498 504 (Pubitemid 30099363)
31. Z. Saikali, and D. Sinnett Expression of glypican 3 (GPC3) in embryonal tumors Int J Cancer 89 2000 418 422
32. C. Baer, M. Nees, and S. Breit Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma Int J Cancer 110 2004 687 694 (Pubitemid 38746027)
33. D.L. Zynger, N.D. Dimov, C. Luan, B.T. Teh, and X.J. Yang Glypican 3: a novel marker in testicular germ cell tumors Am J Surg Pathol 30 2006 1570 1575 (Pubitemid 44808793)
34. M. Fasano, N.D. Theise, and M. Nalesnik Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen Mod Pathol 11 1998 934 938 (Pubitemid 28487210)
35. C. Armengol, S. Cairo, M. Fabre, and M.A. Buendia Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model Int J Biochem Cell Biol 43 2011 265 270